Market Value4,714,958,000
Total Holdings97
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
GBT / Global Blood Therapeutics Inc.
IOVA / Iovance Biotherapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
GRTS / Gritstone bio, Inc.
ALT / Altimmune, Inc.
NTRA / Natera, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SCYX / SCYNEXIS, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
TIL / Instil Bio, Inc.
PANA / Panacea Acquisition Corp II - Class A
S / SentinelOne, Inc.
EQRX / EQRx Inc
SPNE / SeaSpine Holdings Corp
DYNS / Dynamics Special Purpose Corp Class A
ZNTL / Zentalis Pharmaceuticals, Inc.
ALPN / Alpine Immune Sciences, Inc.
SIBN / SI-BONE, Inc.
AMN / AMN Healthcare Services, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
LSAQ / LifeSci Acquisition II Corp
HYPR / Hyperfine, Inc.
XLRN / Acceleron Pharma Inc
XLRN / Acceleron Pharma Inc Call
DH / Definitive Healthcare Corp.
NUVB / Nuvation Bio Inc.
REGN / Regeneron Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
INSM / Insmed Incorporated
BHVN / Biohaven Ltd.
NBIX / Neurocrine Biosciences, Inc.
BPMC / Blueprint Medicines Corporation
MLTX / MoonLake Immunotherapeutics
31656R102 / Field Trip Health Ltd. (Canada)
SGHT / Sight Sciences, Inc.
DNAB / Social Capital Suvretta Holdings Corp II
US83444K1135 / SomaLogic Inc
/ Nautilus Biotechnology Inc
ZETA / Zeta Global Holdings Corp.
ESMT / EngageSmart, Inc.
LFST / LifeStance Health Group, Inc.
HCAQ / HealthCor Catalio Acquisition Corp - Class A
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
KYG5960S1241 / Medicus Sciences Acquisition Corp.
DNAC / Social Capital Suvretta Holdings Corp III
DNAA / Social Capital Suvretta Holdings Corp I
/ CareMax Inc
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
CMPX / Compass Therapeutics, Inc.
ZIOP / Alaunos Therapeutics Inc
EXAS / Exact Sciences Corporation
PATH / UiPath Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
SANA / Sana Biotechnology, Inc.
GHRS / GH Research PLC
MRUS / Merus N.V.
TRDA / Entrada Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ATAI / Atai Life Sciences N.V.
IMAB / I-Mab - Depositary Receipt (Common Stock)
HOWL / Werewolf Therapeutics, Inc.
TALS / Talaris Therapeutics Inc
STTK / Shattuck Labs, Inc.
SHC / Sotera Health Company
ARNA / Arena Pharmaceuticals Inc
GLUE / Monte Rosa Therapeutics, Inc.
SLGC / Standard BioTools Inc.
RLMD / Relmada Therapeutics, Inc.
HOLX / Hologic, Inc.
ONCS / OncoSec Medical Inc
MRTX / Mirati Therapeutics, Inc.
OCDX / Ortho Clinical Diagnostics Holdings PLC
HZNP / Horizon Therapeutics Plc
BLSA / BCLS Acquisition Corp - Class A
HSAQ / Health Sciences Acquisitions Corp 2
STVN / Stevanato Group S.p.A.
VIR / Vir Biotechnology, Inc.
CCXI / ChemoCentryx Inc
HARP / Harpoon Therapeutics, Inc.
AVTR / Avantor, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ACAD / ACADIA Pharmaceuticals Inc.
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
MSAC / Medicus Sciences Acquisition Corp - Class A
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
ISEE / IVERIC bio Inc
TNGX / Tango Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
NTLA / Intellia Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
BLU / Bellus Health Inc
RNA / Avidity Biosciences, Inc.
SMFR / Sema4 Holdings Corp - Class A
UNH / UnitedHealth Group Incorporated
ATEC / Alphatec Holdings, Inc.
PFE / Pfizer Inc.
ACIU / AC Immune SA
ARYD / ARYA Sciences Acquisition Corp IV
UTHR / United Therapeutics Corporation
LLY / Eli Lilly and Company
CYTT / Cyteir Therapeutics, Inc.
SGEN / Seagen Inc
GRPH / Graphite Bio, Inc.
ACET / Adicet Bio, Inc.
EPIX / ESSA Pharma Inc.
ELV / Elevance Health, Inc.
CTLT / Catalent, Inc.
KROS / Keros Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CRBU / Caribou Biosciences, Inc.
KZR / Kezar Life Sciences, Inc.
BAX / Baxter International Inc.
ARVN / Arvinas, Inc.
IDYA / IDEAYA Biosciences, Inc.
KYMR / Kymera Therapeutics, Inc.
ABBV / AbbVie Inc.